Image de couverture de livre

Influenza vaccination in Brazil: rationale and caveats

Fuente: Redalyc

Enregistré dans:

Détails bibliographiques
Auteur principal:	Sérgio Souza da Cunha
Format:	Artículo científico
Langue:	en
Publié:	Universidade de São Paulo 2005
Sujets:	Salud Influenza Influenza vaccine Program evaluation Immunization programs
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Implementation of an anti-flu vaccination campaign in a hospital pharmacy service
par: Eva Fernández-Cañabate
Publié: (2020)

Influenza. Vacunas clásicas y novedosas a las puertas de otra pandemia
par: Raiza Martínez
Publié: (2006)

Cobertura y asociación con variables clínicas de la vacunación antineumocócica en la población mayor de 65 años de Tarragona-Valls
par: Olga Ochoa Gondar
Publié: (2005)

Highly Atypical 2025 Influenza A Season in Brazil
par: Tatiana P. Portella, et autres
Publié: (2026)

Genetic Diversity of Highly Pathogenic Avian Influenza Viruses Isolated in Hokkaido, Japan, During Winter 2024-2025.
par: Isoda, Norikazu, et autres
Publié: (2025)

Determinants of vaccination after the Colombian health system reform
par: Naydú Acosta-Ramírez
Publié: (2005)

Influenza Epidemiology and Vaccine Effectiveness Following Funded Influenza Vaccine in Queensland, Australia, 2022
par: Ashish C. Shrestha, et autres
Publié: (2024)

Relação entre morbidade hospitalar e cobertura vacinal contra Influenza A
par: Fernanda Ribeiro Baptista Marques
Publié: (2012)

Unexpected Delayed Incursion of Highly Pathogenic Avian Influenza H5N1 (Clade 2.3.4.4b) Into the Antarctic Region.
par: Lisovski, Simeon, et autres
Publié: (2024)

Burden of Influenza and Cost‐Effectiveness Analysis of Introduction of an Influenza Vaccination Programme Among Older Adults in India
par: Anand Krishnan, et autres
Publié: (2026)

Factores asociados a la transmisión a los convivientes de gripe (H1N1) 2009
par: Hernán Vargas-Leguas
Publié: (2011)

Influenza Vaccine Effectiveness Against Symptomatic Influenza in Primary Care: A Test Negative Case Control Study Over Two Influenza Seasons 2022/2023 and 2023/2024 in Ireland
par: Louise Marron, et autres
Publié: (2024)

Assessment of Influenza Severity in Bhutan by Using WHO Framework Pandemic Influenza Severity Assessment (PISA): An Implementation Research Study
par: Tshering Dorji, et autres
Publié: (2025)

Severe Neurological Complications With Influenza in Vietnamese Children
par: Sy Duc Nguyen, et autres
Publié: (2024)

A Rapid Virus‐Free Method for Producing Influenza HA Immunogen Needed for Preparation of Influenza Vaccine Potency Antisera Reagents
par: Marcus Odin, et autres
Publié: (2024)

Seasonal Influenza Vaccine 2021/2022 Provides Limited Cross Reactivity Against Contemporary Swine Influenza A Virus Strains in Spain
par: Paloma Encinas, et autres
Publié: (2025)

Neurologic Complications of Influenza and Potential Protective Vaccine Effects
par: Ann R. Falsey
Publié: (2025)

Nomenclature for Tracking of Genetic Variation of Seasonal Influenza Viruses
par: Richard A. Neher, et autres
Publié: (2026)

Influenza Vaccine Effectiveness in Australia During 2017–2019
par: Tanya Diefenbach‐Elstob, et autres
Publié: (2025)

Epidemiologic and Virologic Characteristics of Influenza in Lao PDR, 2016–2023
par: Natalie Wodniak, et autres
Publié: (2024)

Influenza A (H1N1). Patrones Radiológicos
par: Dianarelys Villafuerte Delgado
Publié: (2010)

Obesity in Recovery From Influenza‐Like Illness and Effectiveness of Oseltamivir
par: Oanh Ngoc Nguyen, et autres
Publié: (2025)

Influenza‐Related Deaths in the Czech Republic Over 21 Seasons
par: Jan Kyncl, et autres
Publié: (2025)

The Potential for Twice‐Annual Influenza Vaccination to Reduce Disease Burden
par: Shuyi Zhong, et autres
Publié: (2025)

Influenza Vaccine Effectiveness Against Influenza A(H1N1)pdm09‐Associated Hospitalizations With SARI in Beijing, China, in the 2024–2025 Season
par: Chunna Ma, et autres
Publié: (2026)

Comparative Effectiveness of Cell‐Based Versus Egg‐Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022–2023 Season Among Adults 18–64 Years
par: Emily Rayens, et autres
Publié: (2024)

How Has the Disappearance of Influenza B/Yamagata Altered the Proportion of Influenza A and B Cases? Early Findings From Post‐COVID Pandemic Global Surveillance Data
par: Marco Del Riccio, et autres
Publié: (2025)

Sparse Evidence of Influenza C on US Dairy and Beef Cattle Farms
par: Francisco M. Guerra, et autres
Publié: (2025)

The Detection of Influenza Virus Before and During the COVID‐19 Pandemic in Cameroon
par: Gwladys Chavely Monamele, et autres
Publié: (2024)

Inflammation and Cardiac Dysfunction in Hospitalized Patients With Influenza: The FluHeart Study
par: Kristoffer Grundtvig Skaarup, et autres
Publié: (2026)

Meeting Report: Fourth Correlates of Protection for Next Generation Influenza Vaccines
par: Alina Tscherne, et autres
Publié: (2026)

Changing Epidemiological Pattern and Higher Disease Burden of Influenza in China, 2022 to 2025
par: Hairu Yu, et autres
Publié: (2025)

Human Immune Response to Influenza Neuraminidase After Vaccination: A Systematic Review
par: Vardhini Ganesh, et autres
Publié: (2025)

A Framework for Evaluating the Use of Surveillance Systems for Short‐Term Influenza Forecasting
par: Negin Maroufi, et autres
Publié: (2025)

The Global Influenza Hospital Surveillance Network: A Multicountry Public Health Collaboration
par: Marta C. Nunes, et autres
Publié: (2025)

Nivel de conocimiento sobre la Influenza A (H1N1), 2009
par: María E. Dávila
Publié: (2010)

Detection of Antibodies Specific to H5 Avian Influenza Virus in a Sheep in Norway, June 2024, 11 Months After an Outbreak of Highly Pathogenic Avian Influenza in a Nearby Seabird Colony
par: Johanna Hol Fosse, et autres
Publié: (2025)

Evaluating Bacillus Calmette–Guérin Polysaccharide Nucleic Acid as an Adjuvant for Influenza Vaccines in Mice
par: Sijing Yan, et autres
Publié: (2025)

Cardiac Characteristics of Hospitalized Influenza Patients: An Interim Analysis From the FluHeart Study
par: Kristoffer Grundtvig Skaarup, et autres
Publié: (2025)

High‐Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults
par: Arto A. Palmu, et autres
Publié: (2024)